174 related articles for article (PubMed ID: 29304437)
21. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
[TBL] [Abstract][Full Text] [Related]
22. Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression.
Pangburn TO; Georgiou K; Bates FS; Kokkoli E
Langmuir; 2012 Sep; 28(35):12816-30. PubMed ID: 22827285
[TBL] [Abstract][Full Text] [Related]
23. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery.
Su S; Wang H; Liu X; Wu Y; Nie G
Biomaterials; 2013 Apr; 34(13):3523-33. PubMed ID: 23410678
[TBL] [Abstract][Full Text] [Related]
24. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
Peng ZH; Kopeček J
J Am Chem Soc; 2015 Jun; 137(21):6726-9. PubMed ID: 25963409
[TBL] [Abstract][Full Text] [Related]
25. Electroneutral polymersomes for combined cancer chemotherapy.
Aibani N; Nesbitt H; Marino N; Jurek J; O'Neill C; Martin C; Di Bari I; Sheng Y; Logan K; Hawthorne S; McHale A; Callan JF; Callan B
Acta Biomater; 2018 Oct; 80():327-340. PubMed ID: 30201433
[TBL] [Abstract][Full Text] [Related]
26. Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1.
Murata M; Narahara S; Kawano T; Hamano N; Piao JS; Kang JH; Ohuchida K; Murakami T; Hashizume M
Mol Pharm; 2015 May; 12(5):1422-30. PubMed ID: 25811429
[TBL] [Abstract][Full Text] [Related]
27. Stimuli-responsive polymersomes for cancer therapy.
Thambi T; Park JH; Lee DS
Biomater Sci; 2016 Jan; 4(1):55-69. PubMed ID: 26456625
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Tumor Cell-Tumor Microenvironment Component Interactions as Potential Predictors of Patient Response to Napabucasin.
Chang AY; Hsu E; Patel J; Li Y; Zhang M; Iguchi H; Rogoff HA
Mol Cancer Res; 2019 Jul; 17(7):1429-1434. PubMed ID: 31043490
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Drug and Gene Delivery Using Random Cationic Copolymers Forming Stable and pH-Sensitive Polymersomes.
Laskar P; Dey J; Banik P; Mandal M; Ghosh SK
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27879056
[TBL] [Abstract][Full Text] [Related]
30. Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells.
Ali MS; Gill KS; Saglio G; Cilloni D; Soden DM; Forde PF
Bioelectrochemistry; 2018 Aug; 122():84-92. PubMed ID: 29574322
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
32. Polypeptide/doxorubicin hydrochloride polymersomes prepared through organic solvent-free technique as a smart drug delivery platform.
Li M; Lv S; Tang Z; Song W; Yu H; Sun H; Liu H; Chen X
Macromol Biosci; 2013 Sep; 13(9):1150-62. PubMed ID: 23894136
[TBL] [Abstract][Full Text] [Related]
33. The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression.
Li JM; Hsu PC; Kuan FC; Shi CS; Yang CT
Am J Cancer Res; 2022; 12(10):4637-4651. PubMed ID: 36381330
[TBL] [Abstract][Full Text] [Related]
34. Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes.
Li X; Yang W; Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2015 Dec; 220(Pt B):704-14. PubMed ID: 26348387
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells.
Kulkarni P; Haldar MK; You S; Choi Y; Mallik S
Biomacromolecules; 2016 Aug; 17(8):2507-13. PubMed ID: 27303825
[TBL] [Abstract][Full Text] [Related]
36. Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells.
Zhang L; Xing Y; Gao Q; Sun X; Zhang D; Cao G
Biomed Pharmacother; 2017 Sep; 93():1136-1143. PubMed ID: 28738522
[TBL] [Abstract][Full Text] [Related]
37. Acridine Orange Conjugated Polymersomes for Simultaneous Nuclear Delivery of Gemcitabine and Doxorubicin to Pancreatic Cancer Cells.
Anajafi T; Scott MD; You S; Yang X; Choi Y; Qian SY; Mallik S
Bioconjug Chem; 2016 Mar; 27(3):762-71. PubMed ID: 26848507
[TBL] [Abstract][Full Text] [Related]
38. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
39. ROP and ATRP Fabricated Dual Targeted Redox Sensitive Polymersomes Based on pPEGMA-PCL-ss-PCL-pPEGMA Triblock Copolymers for Breast Cancer Therapeutics.
Kumar A; Lale SV; Mahajan S; Choudhary V; Koul V
ACS Appl Mater Interfaces; 2015 May; 7(17):9211-27. PubMed ID: 25838044
[TBL] [Abstract][Full Text] [Related]
40. Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial.
Jonker DJ; Nott L; Yoshino T; Gill S; Shapiro J; Ohtsu A; Zalcberg J; Vickers MM; Wei AC; Gao Y; Tebbutt NC; Markman B; Price T; Esaki T; Koski S; Hitron M; Li W; Li Y; Magoski NM; Li CJ; Simes J; Tu D; O'Callaghan CJ
Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):263-270. PubMed ID: 29397354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
